Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight/obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 12, 2011, Pages

  Cox, Chad L ^a   Stanhope, Kimber L ^a   Schwarz, Jean Marc ^c,d   Graham, James L ^a   Hatcher, Bonnie ^a   Griffen, Steven C ^e   Bremer, Andrew A ^g   Berglund, Lars ^e   McGahan, John P ^f   Keim, Nancy L ^a,b   Havel, Peter J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b U S DEPARTMENT OF AGRICULTURE   (United States)

^c Touro University California   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FRUCTOSE; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; L SELECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; BEVERAGE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; DIET RESTRICTION; ENERGY; FEMALE; FOOD INTAKE; HOSPITAL PATIENT; HUMAN; MALE; NUTRITIONAL REQUIREMENT; OBESITY; OUTCOME ASSESSMENT; OUTPATIENT; PARALLEL DESIGN; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; BEVERAGES; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHEMOKINE CCL2; E-SELECTIN; FEMALE; FRUCTOSE; GLUCOSE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; L-SELECTIN; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PLASMINOGEN ACTIVATOR INHIBITOR 1; POSTPRANDIAL PERIOD; SWEETENING AGENTS;

EID: 83155168431     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1050     Document Type: Article

References (14)

1. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ 2009 Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 119:1322-1334
2. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R 2005 Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111:1448-1454 (Pubitemid 40396812)
3. Giltay EJ, Elbers JM, Gooren LJ, Emeis JJ, Kooistra T, Asscheman H, Stehouwer CD 1998 Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration. Arterioscler Thromb Vasc Biol 18:1716-1722 (Pubitemid 28521060)
4. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y 1996 Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 2:800-803 (Pubitemid 26225097)
5. Bruun JM, Lihn AS, Pedersen SB, Richelsen B 2005 Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J Clin Endocrinol Metab 90:2282-2289 (Pubitemid 40586275)
6. Panahloo A, Mohamed-Ali V, Lane A, Green F, Humphries SE, Yudkin JS 1995 Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene. Diabetes 44:37-42
7. Allison BA, Nilsson L, Karpe F, Hamsten A, Eriksson P 1999 Effects of native, triglyceride-enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells. Arterioscler Thromb Vasc Biol 19:1354-1360 (Pubitemid 29227658)
8. Banfi C, Mussoni L, Risé P, Cattaneo MG, Vicentini L, Battaini F, Galli C, Tremoli E 1999 Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type 1 in cultured HepG2 cells. Circ Res 85:208-217 (Pubitemid 29343320)
9. Marra F, Valente AJ, Pinzani M, Abboud HE 1993 Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. J Clin Invest 92:1674-1680 (Pubitemid 23304529)
10. Stanhope KL, Havel PJ 2008 Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr Opin Lipidol 19:16-24
11. Morino K, Petersen KF, Shulman GI 2006 Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 55(Suppl 2):S9-S15 (Pubitemid 44927027)
12. Pontiroli AE, Frigè F, Paganelli M, Folli F 2009 In morbid obesity, metabolic abnormalities and adhesion molecules correlate with visceral fat, not with subcutaneous fat: effect of weight loss through surgery. Obes Surg 19:745-750
13. Targher G, Bonadonna RC, Alberiche M, Zenere MB, Muggeo M, Bonora E 2001 Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: role of adipose tissue. Diabetes Care 24:1961-1966 (Pubitemid 33716509)
14. Meshkani R, Adeli K 2009 Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 42:1331-1346